Santen Pharmaceutical (SNPHY) Short Interest Ratio & Short Volume $9.65 +0.21 (+2.17%) As of 02/21/2025 02:48 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartFinancialsSEC FilingsShort Interest Santen Pharmaceutical Short Interest DataSanten Pharmaceutical (SNPHY) has a short interest of 8,300 shares. This marks a 295.24% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 14,457 shares to cover all short positions.Current Short Interest8,300 sharesPrevious Short Interest2,100 sharesChange Vs. Previous Month+295.24%Dollar Volume Sold Short$84,992.00Short Interest Ratio0.1 Days to CoverLast Record DateJanuary 31, 2025Today's Trading Volume11,852 sharesAverage Trading Volume14,457 sharesToday's Volume Vs. Average82% Short Selling Santen Pharmaceutical? Sign up to receive the latest short interest report for Santen Pharmaceutical and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSNPHY Short Interest Over TimeSNPHY Days to Cover Over TimeSNPHY Percentage of Float Shorted Over Time Santen Pharmaceutical Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/20258,300 shares $84,992.00 +295.2%N/A0.1 $10.24 1/15/20252,100 shares $20,412.00 +110.0%N/A0.2 $9.72 12/31/20241,000 shares $10,120.00 No ChangeN/A0 $10.12 11/30/2024100 shares $1,061.00 No ChangeN/A0 $10.61 10/31/2024100 shares $1,184.00 -85.7%N/A0 $11.84 10/15/2024700 shares $8,442.00 -12.5%N/A0.3 $12.06 9/30/2024800 shares $10,124.00 -57.9%N/A0.1 $12.66 9/15/20241,900 shares $24,348.50 -17.4%N/A0.5 $12.82 8/31/20242,300 shares $28,508.50 +4.6%N/A1 $12.40 8/15/20242,200 shares $26,554.00 +15.8%N/A0.1 $12.07 Get the Latest News and Ratings for SNPHY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Santen Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. 7/31/20241,900 shares $22,325.00 -24.0%N/A0 $11.75 7/15/20242,500 shares $28,175.00 -3.9%N/A1.9 $11.27 6/30/20242,600 shares $26,520.00 -10.3%N/A0.2 $10.20 6/15/20242,900 shares $29,717.75 +383.3%N/A0.8 $10.25 5/31/2024600 shares $6,160.20 No ChangeN/A0.3 $10.27 4/30/2024100 shares $994.00 No ChangeN/A0 $9.94 4/15/2024100 shares $912.00 No ChangeN/A0 $9.12 3/31/2024100 shares $975.00 No ChangeN/A0.1 $9.75 3/15/2024100 shares $982.42 -99.5%N/A0 $9.82 2/29/202420,800 shares $204,464.00 +20,700.0%N/A0.7 $9.83 2/15/2024100 shares $1,001.00 No ChangeN/A0 $10.01 1/15/2024100 shares $1,014.00 No ChangeN/A0.1 $10.14 11/30/2023900 shares $8,595.45 +80.0%N/A0.4 $9.55 11/15/2023500 shares $4,490.00 +400.0%N/A0.1 $8.98 10/31/2023100 shares $868.50 -85.7%N/A0 $8.69 10/15/2023700 shares $6,204.45 -41.7%N/A0.3 $8.86 9/30/20231,200 shares $10,944.00 -64.7%N/A0.3 $9.12 9/15/20233,400 shares $32,878.00 -30.6%N/A2.1 $9.67 8/31/20234,900 shares $45,300.50 +36.1%N/A1.5 $9.25 8/15/20233,600 shares $33,588.00 -52.6%N/A0.4 $9.33 7/31/20237,600 shares $65,664.00 +216.7%N/A1.4 $8.64 7/15/20232,400 shares $20,040.00 +242.9%N/A0.3 $8.35 6/30/2023700 shares $5,908.00 +16.7%N/A0 $8.44 6/15/2023600 shares $5,100.00 +100.0%N/A0.1 $8.50 5/31/2023300 shares $2,742.00 -25.0%N/A0.2 $9.14 5/15/2023400 shares $3,624.00 No ChangeN/A0.2 $9.06 4/15/2023400 shares $3,296.00 +100.0%N/A0.1 $8.24 3/31/2023200 shares $1,694.00 -60.0%N/A0 $8.47 3/15/2023500 shares $3,810.00 No ChangeN/A0.1 $7.62 2/15/2023100 shares $739.00 -90.0%N/A0 $7.39Has Trump finally met his match? (Ad)Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance to walk away with gains as high as 235%, 459%, and 700% - all while the stock market got cut in half. Could he be right again?Click here for his emergency broadcast... 1/31/20231,000 shares $7,710.00 No ChangeN/A0.2 $7.71 12/30/2022700 shares $5,624.50 -58.8%N/A0.1 $8.04 12/15/20221,700 shares $13,642.50 -74.6%N/A0.2 $8.03 11/30/20226,700 shares $53,600.00 +86.1%N/A0.4 $8.00 11/15/20223,600 shares $27,468.00 +12.5%N/A0.1 $7.63 10/31/20223,200 shares $21,840.00 -94.0%N/A0.1 $6.83 10/15/202253,100 shares $348,336.00 +517.4%N/A0.9 $6.56 9/30/20228,600 shares $58,222.00 +207.1%N/A0.1 $6.77 9/15/20222,800 shares $18,760.00 -85.6%N/A0 $6.70 8/31/202219,500 shares $139,230.00 +236.2%N/A0.3 $7.14 8/15/20225,800 shares $45,396.60 +5,700.0%N/A0.2 $7.83 7/31/2022100 shares $801.50 No ChangeN/A0 $8.02 6/15/2022400 shares $2,916.00 -90.9%N/A0 $7.29 5/31/20224,400 shares $35,310.00 -63.3%N/A0 $8.03 5/15/202212,000 shares $95,520.00 +823.1%N/A0 $7.96 4/30/20221,300 shares $10,517.00 -38.1%N/A0 $8.09 4/15/20222,100 shares $18,270.00 -92.0%N/A0 $8.70 3/31/202226,300 shares $262,474.00 +87.9%N/A0.3 $9.98 3/15/202214,000 shares $152,600.00 -8.5%N/A0.1 $10.90 2/28/202215,300 shares $173,349.00 -26.4%N/A0.1 $11.33 2/15/202220,800 shares $236,496.00 +300.0%N/A0.1 $11.37 1/31/20225,200 shares $58,812.00 +1,200.0%N/A0 $11.31 1/15/2022400 shares $4,864.00 -98.2%N/A0 $12.16 12/31/202121,600 shares $262,980.00 No ChangeN/A0.1 $12.18 11/30/20211,800 shares $23,670.00 -85.9%N/A0 $13.15 11/15/202112,800 shares $178,412.80 +17.4%N/A0.3 $13.94 10/29/202110,900 shares $153,690.00 +10,800.0%N/A0.2 $14.10 10/15/2021100 shares $1,378.00 -98.4%N/A0 $13.78 9/30/20216,400 shares $90,016.00 +52.4%N/A0.2 $14.07 9/15/20214,200 shares $63,798.00 -8.7%N/A0.2 $15.19 8/31/20214,600 shares $69,368.00 -82.4%N/A0 $15.08 8/13/202126,100 shares $389,673.00 -29.3%N/A0.5 $14.93 7/30/202136,900 shares $498,519.00 +738.6%N/A0.6 $13.51 7/15/20214,400 shares $61,908.00 -85.7%N/A0.1 $14.07 6/30/202130,800 shares $425,964.00 -18.5%N/A0.5 $13.83 6/15/202137,800 shares $526,176.00 +384.6%N/A0.3 $13.92 5/28/20217,800 shares $103,896.00 +136.4%N/A0.1 $13.32 5/14/20213,300 shares $44,253.00 -89.2%N/A0 $13.41 4/30/202130,500 shares $393,145.00 -12.6%N/A0.3 $12.89 4/15/202134,900 shares $466,613.00 -44.4%N/A0.2 $13.37 3/31/202162,800 shares $869,780.00 +784.5%N/A0.5 $13.85 3/15/20217,100 shares $96,986.00 -27.6%N/A0.1 $13.66 2/26/20219,800 shares $137,788.00 +38.0%N/A0.1 $14.06 2/12/20217,100 shares $111,399.00 -70.7%N/A0.1 $15.69 1/29/202124,200 shares $400,026.00 +414.9%N/A0.5 $16.53 12/31/202013,200 shares $213,048.00 No ChangeN/A0.2 $16.14 11/30/20203,800 shares $64,284.60 -85.7%N/A0.1 $16.92 11/15/202026,600 shares $434,577.50 +786.7%N/A0.6 $16.34 10/30/20203,000 shares $55,530.00 +66.7%N/A0.2 $18.51 10/15/20201,800 shares $35,928.00 -86.4%N/A0 $19.96Has Trump finally met his match? (Ad)Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance to walk away with gains as high as 235%, 459%, and 700% - all while the stock market got cut in half. Could he be right again?Click here for his emergency broadcast... 9/30/202013,200 shares $271,260.00 -5.7%N/A1.1 $20.55 9/15/202014,000 shares $276,220.00 +225.6%N/A0.5 $19.73 8/31/20204,300 shares $81,958.00 -76.5%N/A0.2 $19.06 8/14/202018,300 shares $342,235.62 +16.6%N/A0.5 $18.70 7/31/202015,700 shares $263,775.70 +31.9%N/A0.5 $16.80 7/15/202011,900 shares $212,534.00 -25.6%N/A0.5 $17.86 6/30/202016,000 shares $294,720.00 +233.3%N/A0.7 $18.42 6/15/20204,800 shares $89,205.60 -65.0%N/A0.2 $18.58 5/29/202013,700 shares $252,011.50 -22.6%N/A0.4 $18.40 5/15/202017,700 shares $313,520.10 +88.3%N/A0.4 $17.71 4/30/20209,400 shares $165,534.00 -40.1%N/A0.1 $17.61 4/15/202015,700 shares $273,337.00 -50.2%N/A0.3 $17.41 3/31/202031,500 shares $535,185.00 +416.4%N/A0.4 $16.99 3/13/20206,100 shares $84,790.00 -72.3%N/A0.1 $13.90 2/28/202022,000 shares $352,660.00 +168.3%N/A0.4 $16.03 SNPHY Short Interest - Frequently Asked Questions What is Santen Pharmaceutical's current short interest? Short interest is the volume of Santen Pharmaceutical shares that have been sold short but have not yet been covered or closed out. As of January 31st, traders have sold 8,300 shares of SNPHY short. Learn More on Santen Pharmaceutical's current short interest. Is Santen Pharmaceutical's short interest increasing or decreasing? Santen Pharmaceutical saw a increase in short interest in January. As of January 31st, there was short interest totaling 8,300 shares, an increase of 295.2% from the previous total of 2,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short Santen Pharmaceutical stock? Short selling SNPHY is an investing strategy that aims to generate trading profit from Santen Pharmaceutical as its price is falling. SNPHY shares are trading up $0.21 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Santen Pharmaceutical? A short squeeze for Santen Pharmaceutical occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SNPHY, which in turn drives the price of the stock up even further. How often is Santen Pharmaceutical's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SNPHY, twice per month. The most recent reporting period available is January, 31 2025. More Short Interest Resources from MarketBeat Related Companies AstraZeneca Short Interest CSPC Pharmaceutical Group Short Interest JCR Pharmaceuticals Short Interest Kyowa Kirin Short Interest Mayne Pharma Group Short Interest Ono Pharmaceutical Short Interest Orion Oyj Short Interest Otsuka Short Interest Otsuka Short Interest Roche Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:SNPHY) was last updated on 2/23/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredNvidia > DeepSeekEveryone's getting it all wrong … Sure, DeepSeek's reveal caused AI stocks to tumble … But, in the long ...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Santen Pharmaceutical Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Santen Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
